If outbreaks occur, it is unclear whether it will be - PowerPoint PPT Presentation

1 / 36
About This Presentation
Title:

If outbreaks occur, it is unclear whether it will be

Description:

If outbreaks occur, it is unclear whether it will be localized zoonoses or wider epidemics. We must remain alert and prepared. ... Both inhibit viral replication. – PowerPoint PPT presentation

Number of Views:45
Avg rating:3.0/5.0
Slides: 37
Provided by: denverinf
Category:

less

Transcript and Presenter's Notes

Title: If outbreaks occur, it is unclear whether it will be


1
Influenza in the 21st Century and the Risk of a
Pandemic
  • Michelle A. Barron, M.D.
  • Assistant Professor of Medicine
  • Division of Infectious Diseases
  • UCHSC, Denver, CO

2
(No Transcript)
3
Influenza virus
  • Family Orthomyxoviridae.
  • Single stranded RNA virus.
  • Zoonosis of swine, birds, horses, and humans.
  • 3 Distinct types
  • Influenza A virus
  • Influenza B virus
  • Influenza C virus

4
History of Influenza
  • Estimated 51,000 excess deaths annually in the US
    from influenza.
  • Thought to have appeared in the first half of the
    16th century.
  • ex influentia colesti Italian expression
    which alluded to the thought that the epidemic
    was due to celestial influence.
  • The 1510 pandemic began in Sicily, spread to
    Italy and to the rest of Europe.
  • Hundreds of thousands of individuals affected.

Cunha, B.A. Infect Dis Clin N Am 18 (2004)
141-155.
5
Influenza pandemic of 1918-1919 Spanish flu
  • Spanish flu A (H1N1) originated in the U.S. and
    was transported to Europe by American troops
    fighting in World War I.
  • More than half a million deaths in the US alone.
  • 20-50 million people may have died worldwide.

Cunha, B.A. Infect Dis Clin N Am 18 (2004)
141-155.
6
Spanish Flu 1918-1919
  • Unusually high mortality in healthy young adults.
  • Single most lethal infectious outbreak to occur
    worldwide over a 1-year period.
  • Small pox took half a century to move across
    Europe.

Cunha, B.A. Infect Dis Clin N Am 18 (2004)
141-155.
7
History of Influenza
  • 1933 Influenza A is isolated.
  • 1936 Influenza is grown in embryonated eggs.
  • 1939 Influenza B is isolated.
  • 1941 Hemagglutination reactions discovered.
  • 1950 Influenza C virus isolated.

Cunha, B.A. Infect Dis Clin N Am 18 (2004)
141-155.
8
History of Influenza
  • 1957-58 Asian flu A (H2N2)
  • 70,000 deaths in the US.
  • First to be studied using modern scientific
    techniques.
  • 1968-69 Hong Kong flu A (H3N2)
  • Approximately 34,000 deaths in the U.S.
  • Both 1957 and 1968 pandemics due to reassortment
    of a human virus with an avian influenza virus.

Cunha, B.A. Infect Dis Clin N Am 18 (2004)
141-155.
9
Epidemiology of Influenza
  • Hemagglutinin (HA)
  • 15 distinct HAs (numbered 1-15).
  • Important in attaching and infecting respiratory
    epithelial cells by cell fusion.
  • Neuraminidase (NA)
  • 9 distinct NAs (numbered 1-9).
  • Important in the release of influenza viruses
    from the apices of infected cells facilitating
    cell-to-cell spread of the virus.
  • Only 3 HA subtypes (H1, H2, H3) and two NA
    subtypes (N1, N2) have caused influenza epidemics.

10
Epidemiology of Influenza
  • Antigenic Shift
  • Seen only with Influenza A viruses.
  • Results from replacement of HA and sometimes NA
    with novel subtypes not present in human viruses.
  • Source of new genes is large reservoir of
    influenza viruses in waterfowl.

11
Epidemiology of Influenza
  • Antigenic Drift
  • Occurs in both influenza A and B.
  • Pattern observed is somewhat different for each
    virus.
  • Involves the accumulation of mutations within the
    antibody-binding sites in HA, the NA, or both.

12
Adapted from NEJM. 2004. 350(3)219.
13
Clinical Features - Adults
  • Incubation period of 1-5 days.
  • Abrupt onset of severe headache, chills, and
    non-productive cough.
  • Also prominent muscle aches accompanied by high
    fevers.
  • Fever peaks on the first day and may decrease
    over the next 72 hours.
  • Decreased energy and appetite are universal.
  • Mild-moderate cases usually resolve in 7 days.
  • Weakness, cough, and lack of energy may persist
    for weeks after clinical resolution.

14
Clinical Features - Children
  • Similar syndrome in children, except croup is
    common in kids lt1 year old.
  • Nausea, vomiting, and abdominal pain more common
    complaints in children lt 3 years of age.
  • Inflammation in the muscles of the calf are
    common.
  • Febrile seizures may occur.
  • Encephalitis may accompany illness.

15
Prevention and Good Health Habits
  • Vaccination is the key prevention strategy.
  • Stay home when you are sick.
  • Avoid direct contact with people that are
    coughing or sneezing.
  • Cover your mouth when you cough or sneeze.
  • Wash your hands frequently or use antibacterial
    gels frequently.

16
Antiviral Drugs Amantadine Rimantadine
  • Effective against influenza A only.
  • Both inhibit viral replication.
  • Prophylaxis is preventative in about 50 of
    infections and 70-90 of illnesses.
  • Must be given daily throughout the period of
    exposure.
  • Effective for the treatment of influenza A if
    given during the first 2 days of illness.
  • Resistance can develop rapidly during treatment.
  • Has been recognized in 25-35 of treated
    patients.

Couch, R.B. NEJM. 2000. 343(24)1778-87.
17
Antiviral Drugs Zanamivir and Oseltamivir
  • Neuraminidase inhibitors.
  • Effective against both influenza A and B viruses.
  • Approved for treatment of influenza only in
    person with symptoms lt2 days.
  • Reduces symptoms by 1-1.5 days.
  • Both have been shown to prevent influenza if
    given before exposure during a community epidemic.

Couch, R.B. NEJM. 2000. 343(24)1778-87.
18
Pandemic Influenza Strains
  • Sources
  • Avian influenza viruses thought to be likely
    source of reassortment.
  • Pigs have receptors for avian and human influenza
    viruses and are susceptible to both.
  • Possible intermediary for viral reassortment.
  • Features
  • Highly pathogenic for humans.
  • Easily transmitted between humans.
  • Genetically unique (lack of preexisting immunity
    in the human population.)

19
Seasonal versus Pandemic Influenza
  • Seasonal Flu
  • Outbreaks follow predictable seasonal patterns
  • Usually some immunity built up from previous
    exposure
  • Healthy adults usually not at risk for serious
    complications
  • Health systems can usually meet public and
    patient needs
  • Pandemic Flu
  • Occurs rarely (three times in 20th century - last
    in 1968)
  • No previous exposure little or
  • no pre-existing immunity
  • Healthy people may be at increased risk for
    serious complications
  • Health systems may be overwhelmed

20
Seasonal versus Pandemic Influenza
  • Vaccine developed based on known flu strains and
    available for annual flu season
  • Adequate supplies of antivirals are usually
    available
  • Average U.S. deaths approximately 36,000/yr
  • Symptoms fever, cough, runny nose, muscle pain.
    Deaths often caused by complications, such as
    pneumonia
  • Generally causes modest impact on society (e.g.,
    some school closing, encouragement of people who
    are sick to stay home)
  • Manageable impact on domestic and world economy
  • Vaccine probably would not be available in the
    early stages of a pandemic
  • Effective antivirals may be in limited supply
  • Number of deaths could be quite high (e.g., U.S.
    1918 death toll approximately 500,000)
  • Symptoms may be more severe and complications
    more frequent
  • May cause major impact on society (e.g.
    widespread restrictions on travel, closings of
    schools and businesses, cancellation of large
    public gatherings)
  • Potential for severe impact on domestic and world
    economy

21
Moderate and Severe Influenza Scenarios
22
Current H5N1 Threat
  • Virus has spread rapidly throughout poultry
    flocks in Asia in past 2 years.
  • The subtype mutates rapidly.
  • Has shown a propensity to acquire genes from
    viruses infecting other species.
  • Causes severe disease in humans with high
    case-fatality rate.
  • Notable that sustained human-to-human
    transmission has not occurred.
  • Potential of exposure and infection in humans is
    likely ongoing in rural Asia.

23
(No Transcript)
24
Avian influenza A (H5N1)
  • December 2003
  • 19,000 of 24,000 chickens on a farm in Korea die
    in a week.
  • Epidemic of the highly pathogenic avian influenza
    H5N1 strain found as the cause of the poultry
    deaths.
  • More than 1.3 million chickens and ducks have
    died or been destroyed.
  • January 2004
  • Outbreak of severe respiratory illness in 12
    previously healthy children and 1 adult
    hospitalized in Viet Nam reported to WHO 8
    cases are fatal.
  • Test on samples from two of the fatal cases
    confirm infection with H5N1 avian influenza virus
    strain.

WHO. 2004
25
Avian influenza A (H5N1)
  • H5N1 outbreaks poultry in Cambodia, China,
    Indonesia, China, Japan, Laos, South Korea,
    Thailand and Vietnam reported.
  • Millions of birds either died from the disease or
    were culled in efforts to contain the outbreaks.
  • February 2004
  • 34 human cases with 23 deaths reported in
    Thailand and Vietnam.
  • August/September/October 2004
  • 4 human deaths from avian influenza H5 infection
    reported in Vietnam 4 fatal cases in Thailand..
  • 1 case of possible human-to-human transmission
    reported.

WHO. 2004
26
Avian influenza A (H5N1)
  • December 2004
  • Resurgence of poultry outbreaks and human cases
    reported in Vietnam.
  • Suggested transmission to at least two persons
    through consumption of uncooked duck blood.
  • February 2, 2005
  • The first of 4 human cases of H5N1 infection from
    Cambodia was reported.
  • July 21, 2005
  • First human case of H5N1 in Indonesia was
    reported.
  • Indonesia has continued to report human cases in
    August, September, and October 2005.

27
Avian influenza A (H5N1)
  • January 2006
  • Two cases of avian influenza in Turkey and 1st
    case detected in Iraq.
  • February 2006
  • China reports its 12 case and 8th fatality.
    Indonesia reports its 25th case and 18th
    fatality. Iraq reports its 2nd case.
  • March 2006
  • Azerbaijan and Egypt report their 1st human
    cases.
  • August 2006
  • 60 cases confirmed to date in Indonesia, 46 have
    been fatal .

28
Cumulative Number of Confirmed Human Cases of
Avian Influenza A/(H5N1) Reported to WHO
Total number of cases includes number of
deaths.WHO reports only laboratory-confirmed
cases. Adapted from CDC (August 23, 2006)
29
Nations With Confirmed Cases H5N1 Avian
Influenza (July 7, 2006)
Adapted from CDC
30
Symptoms of Avian flu in Humans
  • Range of symptoms.
  • Typical flu-like symptoms (fever, cough, sore
    throat and muscle aches),
  • Eye infections,
  • Pneumonia,
  • Severe respiratory diseases (such as acute
    respiratory distress),
  • and other severe and life-threatening
    complications such as encephalitis.
  • The symptoms may depend on which virus caused the
    infection.

31
Advice to Travelers
  • Avoid all direct contact with poultry, including
    touching well-appearing, sick, or dead chickens
    and ducks.
  • Avoid places such as poultry farms and bird
    markets where live poultry are raised or kept,
    and avoid handling surfaces contaminated with
    poultry feces or secretions.
  • Cleaning hands often with soap and water.
  • Waterless alcohol-based hand gels may be used
    when soap is not available and hands are not
    visibly soiled.
  • All foods from poultry, including eggs and
    poultry blood, should be thoroughly cooked.

32
Treatment Options and Prevention
  • The current H5N1 virus infecting birds in Asia
    that has caused human illness and death is
    resistant to amantadine and rimantadine.
  • Oseltamavir and zanamavir would probably work to
    treat flu caused by the H5N1 virus, but
    additional studies still need to be done.
  • No commercially available vaccine to protect
    humans against the H5N1 virus that is being seen
    in Asia and Europe .

33
Ten Things You Need to Know About Pandemic
Influenza
  • 1. Pandemic influenza is different from avian
    influenza.
  • 2. Influenza pandemics are recurring events.
  • 3. The world may be on the brink of another
    pandemic.
  • 4. All countries will be affected.
  • 5. Widespread illness will occur.
  • 6. Medical supplies will be inadequate.
  • 7. Large numbers of deaths will occur.
  • 8. Economic and social disruption will be great.
  • 9. Every country must be prepared.
  • 10. WHO will alert the world when the pandemic
    threat increases.

34
What Does the Future Hold?
  • It is unclear whether additional global outbreaks
    of influenza or some other emerging infectious
    disease will occur.
  • If outbreaks occur, it is unclear whether it will
    be localized zoonoses or wider epidemics.
  • We must remain alert and prepared.

35
  • Chance Favors the Prepared Mind.
  • Louis Pasteur

36
Questions?
Write a Comment
User Comments (0)
About PowerShow.com